trimethoprim has been researched along with Arthritis, Juvenile Chronic in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Excerpt | Relevance | Reference |
---|---|---|
"Two months later, Pneumocystis carinii pneumonia developed." | 1.29 | Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. ( De Benedetti, F; Martini, A; Ravelli, A; Viola, S, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ravelli, A | 1 |
De Benedetti, F | 1 |
Viola, S | 1 |
Martini, A | 1 |
1 other study available for trimethoprim and Arthritis, Juvenile Chronic
Article | Year |
---|---|
Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.
Topics: Anti-Infective Agents; Antirheumatic Agents; Arthritis, Juvenile; Bone Marrow; Child; Cyclosporine; | 1996 |